Glode LM - Search Results

Year	Number of Results
1975	1
1976	3
1977	3
1979	5
1981	5
1982	3
1983	4
1984	5
1985	5
1986	6
1987	3
1988	1
1989	1
1990	2
1991	4
1992	3
1994	2
1995	1
1996	1
1997	2
1998	1
1999	1
2000	4
2001	3
2002	1
2003	8
2004	5
2006	5
2007	8
2008	3
2010	1
2011	6
2012	2
2013	6
2014	2
2015	2
2016	1
2018	3
2019	1
2020	2
2022	1
2024	0

1

Neoadjuvant and adjuvant hormonal and chemotherapy for prostate cancer.

Lam ET, Glodé LM. Lam ET, et al. Among authors: glode lm. Hematol Oncol Clin North Am. 2013 Dec;27(6):1189-204, viii. doi: 10.1016/j.hoc.2013.08.004. Epub 2013 Sep 21. Hematol Oncol Clin North Am. 2013. PMID: 24188258 Review.

2

Cloning, sequence determination, and expression in transfected cells of the coding sequence for the tox 176 attenuated diphtheria toxin A chain.

Maxwell F, Maxwell IH, Glode LM. Maxwell F, et al. Among authors: glode lm. Mol Cell Biol. 1987 Apr;7(4):1576-9. doi: 10.1128/mcb.7.4.1576-1579.1987. Mol Cell Biol. 1987. PMID: 3110596 Free PMC article.

3

Metabolic syndrome and prostate cancer.

Glode LM. Glode LM. Cancer. 2008 May 15;112(10):2103-5. doi: 10.1002/cncr.23511. Cancer. 2008. PMID: 18404693 Free article. No abstract available.

4

Current challenges of gene therapy for prostate cancer.

Harrison GS, Glode LM. Harrison GS, et al. Among authors: glode lm. Oncology (Williston Park). 1997 Jun;11(6):845-50, 856; discussion 856-8, 861. Oncology (Williston Park). 1997. PMID: 9189941 Free article. Review.

5

LHRH.

Glode LM, Smith JA. Glode LM, et al. JAMA. 1985 Jul 26;254(4):506-7. doi: 10.1001/jama.254.4.506b. JAMA. 1985. PMID: 3892064 No abstract available.

6

Reconsidering the Trade-offs of Prostate Cancer Screening.

Wittmann D, Skolarus T, Glodé LM. Wittmann D, et al. Among authors: glode lm. N Engl J Med. 2020 Sep 24;383(13):1289-1290. doi: 10.1056/NEJMc2025138. N Engl J Med. 2020. PMID: 32966735 No abstract available.

7

High-risk localized prostate cancer: primary surgery and adjuvant therapy.

Skinner EC, Glode LM. Skinner EC, et al. Among authors: glode lm. Urol Oncol. 2003 May-Jun;21(3):219-27. doi: 10.1016/s1078-1439(03)00018-8. Urol Oncol. 2003. PMID: 12810210 Review.

8

Management of the side effects of androgen deprivation therapy in men with prostate cancer.

Flaig TW, Glodé LM. Flaig TW, et al. Among authors: glode lm. Expert Opin Pharmacother. 2008 Nov;9(16):2829-41. doi: 10.1517/14656566.9.16.2829. Expert Opin Pharmacother. 2008. PMID: 18937615 Review.

9

Cystathionine metabolism in neuroblastoma.

Klein CE, Roberts B, Holcenberg J, Glode LM. Klein CE, et al. Among authors: glode lm. Cancer. 1988 Jul 15;62(2):291-8. doi: 10.1002/1097-0142(19880715)62:2<291::aid-cncr2820620211>3.0.co;2-q. Cancer. 1988. PMID: 3383129

10

Gonadotropin-releasing hormone and its receptor in normal and malignant cells.

Harrison GS, Wierman ME, Nett TM, Glode LM. Harrison GS, et al. Among authors: glode lm. Endocr Relat Cancer. 2004 Dec;11(4):725-48. doi: 10.1677/erc.1.00777. Endocr Relat Cancer. 2004. PMID: 15613448 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

122 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Results by year